NeuPath Net Receivables from 2010 to 2026

NPTH Stock  CAD 0.46  0.03  6.12%   
NeuPath Health Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables will likely drop to about 6.7 M in 2026. During the period from 2010 to 2026, NeuPath Health Net Receivables regression line of quarterly data had mean square error of 989 B and geometric mean of  4,377,788. View All Fundamentals
 
Net Receivables  
First Reported
2020-03-31
Previous Quarter
9.4 M
Current Value
M
Quarterly Volatility
854.8 K
 
Covid
 
Interest Hikes
Check NeuPath Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuPath Health's main balance sheet or income statement drivers, such as Interest Expense of 960.6 K, Income Tax Expense of 234.3 K or Tax Provision of 137.1 K, as well as many indicators such as . NeuPath financial statements analysis is a perfect complement when working with NeuPath Health Valuation or Volatility modules.
  
This module can also supplement various NeuPath Health Technical models . Check out the analysis of NeuPath Health Correlation against competitors.
The evolution of Net Receivables for NeuPath Health provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how NeuPath Health compares to historical norms and industry peers.

Latest NeuPath Health's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of NeuPath Health over the last few years. It is NeuPath Health's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeuPath Health's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

NeuPath Net Receivables Regression Statistics

Arithmetic Mean4,865,795
Geometric Mean4,377,788
Coefficient Of Variation45.46
Mean Deviation2,041,219
Median5,153,000
Standard Deviation2,212,098
Sample Variance4.9T
Range5.8M
R-Value0.90
Mean Square Error989B
R-Squared0.81
Slope394,384
Total Sum of Squares78.3T

NeuPath Net Receivables History

20266.7 M
20258.5 M
20247.4 M
20236.7 M
2022M
20216.6 M
20205.9 M

About NeuPath Health Financial Statements

NeuPath Health investors use historical fundamental indicators, such as NeuPath Health's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NeuPath Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables8.5 M6.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.